Related Experiment Video

Updated: Nov 21, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.1K

Integrated cardiovascular risk management programme versus usual care in patients at high cardiovascular risk: an

Suzanne Marchal1, Arnoud Wj van 't Hof2,3,4, Henk Jg Bilo4,5

  • 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands s.marchal@umcutrecht.nl.

BJGP Open
|January 13, 2021
PubMed

Insights

Integrated cardiovascular risk management (CVRM) programs in primary care did not significantly reduce systolic blood pressure (SBP) or low-density lipoprotein (LDL)-cholesterol in high-risk patients. Further research is needed to enhance CVRM effectiveness.

Area of Science:

  • Cardiology
  • Public Health
  • General Practice

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of mortality.
  • Risk factor control in high-risk patients remains suboptimal.
  • Integrated multidisciplinary cardiovascular risk management (CVRM) programs are emerging in primary care settings.

Purpose of the Study:

  • To evaluate the impact of an integrated CVRM program on systolic blood pressure (SBP) and low-density lipoprotein (LDL)-cholesterol.
  • To compare the effectiveness of integrated CVRM with usual care in high-risk patients.

Main Methods:

  • A prospective observational study compared integrated CVRM with usual care in Dutch general practices.
  • Patients (40-80 years) at high cardiovascular risk were matched at baseline.
  • Primary outcomes included SBP and LDL-cholesterol; secondary outcomes covered CV risk, BMI, lifestyle, and health outcomes over 1 year.

Main Results:

  • No significant differences in SBP or LDL-cholesterol were observed between the integrated CVRM and usual care groups after 1 year.
  • Secondary outcomes, including 10-year CV risk, BMI, and lifestyle factors, also showed no significant differences.
  • The study included 372 patients in the intervention group and 317 in the usual care group.

Conclusions:

  • Integrated CVRM delivered in general practice did not demonstrate improved SBP or LDL-cholesterol levels in high-risk patients.
  • Current integrated CVRM approaches require further investigation and refinement for enhanced effectiveness.
  • Additional research is necessary to optimize cardiovascular risk management strategies in primary care.
Abstract

Keywords:
cardiovascular diseasesdelivery of health care, integratedgeneral practiceprevention

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

19.4K

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
476
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
125
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
126
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
267
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
131